Igene Biotechnology, Inc.
IGNE · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -48.2% | 234.3% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 25.7% | 16.3% | 26.5% | – |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -21.5% | -27.2% | 14.2% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.6% | -52.2% | -83% | – |
| EPS Diluted | -0 | -0.021 | -0.017 | -0.011 |
| % Growth | 99.5% | -23.1% | -61.7% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |